Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) is proud to confirm that Express Scripts, a leading pharmacy benefit management organization, will list Viatris'...

Related Keywords

Shanghai ,China ,Hyderabad ,Andhra Pradesh ,India ,Biocon Biologics ,Tony Mauro ,Linkedin ,Script National Preferred Formulary ,Twitter ,National Preferred Formulary ,Drug Administration ,Nasdaq ,Exchange Commission ,Youtube ,Pfizer Inc ,Viatris Inc ,Express Scripts ,National Preferred ,Insulin Glargine ,Express Script National Preferred Formulary ,Developed Markets ,Insulin Glargine Yfgn Injection ,Important Safety ,Global Healthcare ,Private Securities Litigation Reform Act ,Fair Disclosure ,